The Role of Anaerobes in Patients With Ventilator-associated Pneumonia and Aspiration Pneumonia

CHEST Journal ◽  
1999 ◽  
Vol 115 (1) ◽  
pp. 178-183 ◽  
Author(s):  
Paul E. Marik ◽  
Pamela Careau
Keyword(s):  
Aspiration Pneumonia ◽  
Ventilator Associated Pneumonia

The role of surveillance cultures in guiding ventilator-associated pneumonia therapy

2014 ◽  
Vol 27 (2) ◽  
pp. 184-193 ◽  
Author(s):  
Carlos M. Luna ◽  
Ignacio Bledel ◽  
Alejandro Raimondi
Keyword(s):  
Ventilator Associated Pneumonia ◽  
Surveillance Cultures

The role of the gastric reservoir in ventilator-associated pneumonia

1995 ◽  
Vol 6 (4) ◽  
pp. 174-180 ◽  
Author(s):  
A TORRES ◽  
M EL-EBIARY ◽  
N SOLER ◽  
C MONTÓN ◽  
J GONZÁLEZ ◽  
...  
Keyword(s):  
Ventilator Associated Pneumonia

scholarly journals Serum Procalcitonin Level and Mortality Risk in Critically ill Patients with Ventilator-Associated Pneumonia

2015 ◽  
Vol 37 (5) ◽  
pp. 1967-1972 ◽  
Author(s):  
Bo Li ◽  
Xin Zhao ◽  
Shumei Li
Keyword(s):  
Critically Ill ◽  
Mortality Risk ◽  
Critically Ill Patients ◽  
Cox Regression ◽  
High Serum ◽  
Ventilator Associated Pneumonia ◽  
Prognostic Role ◽  
Procalcitonin Level ◽  
Increased Risk

Background/Aims: The prognostic role of serum procalcitonin level in critically ill patients with ventilator-associated pneumonia was unclear. The aim of our study was to investigate the relationship between serum procalcitonin level and mortality risk in critically ill patients with ventilator-associated pneumonia. Methods: Data of critically ill patients with ventilator-associated pneumonia were retrospectively collected. Demographics, comorbidities, and serum procalcitonin level were extracted from electronic medical records. The primary outcome was mortality within two months after diagnosis. Multivariable Cox regression analyses were performed to assess the prognostic role of serum procalcitonin level in those patients. Results: A total of 115 critically ill patients with ventilator-associated pneumonia were enrolled in our study. Serum procalcitonin level was not associated with age, gender, or other comorbidities. Univariate Cox regression model showed that high serum procalcitonin level was associated increased risk of morality within 2 months after diagnosis (OR = 2.32, 95% CI 1.25-4.31, P = 0.008). Multivariable Cox regression model showed that high serum procalcitonin level was independently associated increased risk of morality within 2 months after diagnosis (OR = 2.38, 95% CI 1.26-4.50, P = 0.008). Conclusion: High serum procalcitonin level is an independent prognostic biomarker of mortality risk in critically ill patients with ventilator-associated pneumonia, and it's a promising biomarker of prognosis in critically ill patients.

Clinical and hemostatic responses to treatment in ventilator-associated pneumonia: Role of bacterial pathogens*

2007 ◽  
Vol 35 (2) ◽  
pp. 490-496 ◽  
Author(s):  
Ali A. El Solh ◽  
Goda Choi ◽  
Marcus J. Schultz ◽  
Lilibeth A. Pineda ◽  
Corey Mankowski
Keyword(s):  
Bacterial Pathogens ◽  
Ventilator Associated Pneumonia

scholarly journals EARLY PROBIOTICS IN PREVENTING VENTILATOR-ASSOCIATED PNEUMONIA AFTER MULTIPLE TRAUMA

2020 ◽  
pp. 83-85
Author(s):  
TAMER HABIB ◽  
AMIRA B KASSEM ◽  
ISLAM AHMED
Keyword(s):  
Multiple Trauma ◽  
University Hospital ◽  
Control Group ◽  
Trauma Patients ◽  
Ventilator Associated Pneumonia ◽  
Mechanically Ventilated ◽  
Significant Difference ◽  
Multiple Trauma Patients ◽  
And Control

Objective: Using probiotics in preventing ventilator-associated pneumonia (VAP) remain controversial due to different intensive care unit (ICU) populations included in such studies. The aim of this study is to evaluate the role of probiotics in prophylaxis of VAP after multiple trauma. Methods: Sixty-five adult multiple trauma patients on mechanical ventilator (expected ≥48 h) after admission to the Critical Care Medicine Department, Alexandria Main University Hospital from June to November 2018. Patients were randomly assigned using computer sheet into two groups; probiotics group (32 patients received one Lacteol Forte® sachet through orogastric/nasogastric tube 3 times daily during their ICU stay) and control group (33 patients received similar regimen of placebo sachets). All patients were followed up and subjected to all possible strategies of the diagnosis of microbiologically confirmed VAP. Results: Sixty-five patients were enrolled with a mean of age (39.48±7.692) years, 80% of them were male. Regarding the incidence of VAP, it was 18.46% of all patients without statistically significant difference between probiotics group (15.63%) and control group (21.21%) (p=0.751). Conclusion: Routine use of early probiotics in mechanically ventilated multiple trauma patients was not associated with lower incidence of VAP, duration of MV, or ICU mortality.

scholarly journals Ventilator-Associated Pneumonia: Role of Anaerobes

1999 ◽  
Vol 20 (4) ◽  
pp. 241-241
Author(s):  
Gina Pugliese ◽  
Martin S. Favero
Keyword(s):  
Ventilator Associated Pneumonia
Sign in / Sign up

Export Citation Format

Share Document